Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NC-6004 plus gemcitabine vs gemcitabine alone in advanced pancreatic cancer
jRCT2080223564Phase 3Completed
- Sponsor
- NanoCarrier Co., Ltd.
- Start
- Jun 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01
Overview
Phase 3, randomised, open-label trial in pancreatic cancer (PC) comparing NC-6004 + gemcitabine with Gemcitabine alone (2 arms). Started Jun 2017; status: completed.
02
Drugs
demplatin pegraglumergemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on jRCT2080223564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223564.